Cargando…
Amniotic Membrane Scaffolds Support Organized Muscle Regeneration in A Murine Volumetric Muscle Defect Model
Current treatment for volumetric muscle loss is limited to muscle transfer or acellular collagen scaffold (ACS) therapies that are associated with donor site morbidity and nonfunctional fibrosis, respectively. The aim of this study is to assess the utility of amniotic membrane scaffold (AMS) for vol...
Autores principales: | Awad, Mohamed, Kurlander, David E., Kotha, Vikas S., Malone, Kevin, Davidson, Edward H., Kumar, Anand R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473793/ https://www.ncbi.nlm.nih.gov/pubmed/36119379 http://dx.doi.org/10.1097/GOX.0000000000004499 |
Ejemplares similares
-
Biomimetic glycosaminoglycan-based scaffolds improve skeletal muscle regeneration in a Murine volumetric muscle loss model
por: Narayanan, Naagarajan, et al.
Publicado: (2020) -
Biodegradability of Amniotic Membrane as Potential Scaffold for Periodontal Regeneration
por: Ling, Kung Ee, et al.
Publicado: (2023) -
Neutrophil and natural killer cell imbalances prevent muscle stem cell–mediated regeneration following murine volumetric muscle loss
por: Larouche, Jacqueline A., et al.
Publicado: (2022) -
Highly Porous Foam Scaffolds Imprinted with human iPSCs Regenerate Skeletal Muscle and Improve Function Following Volumetric Muscle Loss
por: Zhu, Christina, et al.
Publicado: (2023) -
Progressive Muscle Cell Delivery as a Solution for Volumetric Muscle Defect Repair
por: Kim, Ji Hyun, et al.
Publicado: (2016)